Market revenue in 2023 | USD 10.8 million |
Market revenue in 2030 | USD 20.6 million |
Growth rate | 9.7% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 58.33% in 2023. Horizon Databook has segmented the Indonesia deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
Indonesia deep brain stimulation devices market is expected to grow moderately over the forecast period owing to the increase in healthcare expenditure and implementation of Jaminan Kesehatan Nasional (JKN) insurance policy in Indonesia since 2016.
Moreover, rise in disposable income and political factors have driven the growth of deep brain stimulation devices market in this country. Furthermore, within the purview of new insurance policy, all the previous schemes will be merged and the private insurance providers cover both inpatient and outpatient services.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account